-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Aeterna Zentaris (NASDAQ:AEZS) Earns Sell Rating from Analysts at StockNews.com
Equities researchers at StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a research report issued on Friday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Aeterna Zentaris Price Performance AEZS stock opened at $2.83 on Friday. The business has a 50 day simple moving average […]
Equities researchers at StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a research report issued on Friday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Aeterna Zentaris Price Performance AEZS stock opened at $2.83 on Friday. The business has a 50 day simple moving average […]
